Rescue Biomedical wins $2.8M grant for nalaxone-releasing implant for opioid overdoses

[Photo courtesy of Purdue/Rescue Biomedical/Hugh Lee]Rescue Biomedical announced today that it received a $2.8 million grant from the National Institutes of Health for its opioid overdose treatment.

West Lafayette, Indiana received a Fast-Track Small Business Innovation Research, or SBIR, grant from the NIH. The company develops technology that detects when a person is overdosing on an opioid and delivers naloxone to reverse the action.

The minimally invasive, subcutaneous device presents a closed-loop drug delivery system. Hyowon “Hugh” Lee, Rescue Biomedical CEO, said the company seeks to partner with recovery clinics and clinicians. This way, they can identify and work with opioid use disorder (OUD) patients at high risk of overdosing again.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0